Synergy between preactivated photofrin-II and tamoxifen in killing retrofibroma, pseudomyxoma and breast cancer cells
- 31 August 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (8), 1034-1039
- https://doi.org/10.1016/0277-5379(91)90276-j
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- TUMOR CELL SPECIFIC DARK CYTOTOXICITY OF LIGHT‐EXPOSED MEROCYANINE 540: IMPLICATIONS FOR SYSTEMIC THERAPY WITHOUT LIGHTPhotochemistry and Photobiology, 1990
- Preactivation—a novel antitumour and antiviral approachEuropean Journal of Cancer and Clinical Oncology, 1990
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycleEuropean Journal of Cancer and Clinical Oncology, 1983
- The metabolism of tamoxifen in humansBiochemical Pharmacology, 1979
- Estrogen Control of Progesterone Receptor in Human Breast Cancer: Role of Estradiol and Antiestrogen*Endocrinology, 1978
- Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligandsJournal of Theoretical Biology, 1976
- Photoaffinity labels for estrogen binding proteins of rat uterusBiochemistry, 1973
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971
- A NEW DERIVATIVE OF TRIPHENYLETHYLENE: EFFECT ON IMPLANTATION AND MODE OF ACTION IN RATSReproduction, 1967
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949